Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of diagnosing or treating prostate cancer using the ERG gene, alone or in combination with other over or under expressed genes in prostate cancer

Methods of diagnosing or treating prostate cancer using the ERG gene, alone or in combination with other over or under expressed genes in prostate cancer

US Patent 11236395 · Granted Feb 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Markers for the diagnosis of biochemical recurrence in prostate cancer2025
Prostate cancer gene profiles and methods of using the same2024
Prostate cancer gene profiles and methods of using the same2024
Azophenols as ERG oncogene inhibitors2023
ERG monoclonal antibodies2022
Genomic rearrangements associated with prostate cancer and methods of using the 2020
Genomic rearrangements associated with prostate cancer and methods of using the 2020
Prostate cancer-specific alterations in ERG gene expression and detection and tr2019
Prostate cancer-specific alterations in ERG gene expression and detection and tr2019
Azophenols as ERG oncogene inhibitors2019
Prostate cancer gene expression profiles2018
Prostate cancer gene expression profiles2018